Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.32 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 2/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.30 |
| ▸ | GLUL | P15104 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4514628 | 1.00 | ALDH1A1 (0.35) | ALDH1A1MEN1TSHRKMT2AHCRTR1 | |
| SCHEMBL4498950 | 0.77 | ALDH1A1 (0.36) | ALDH1A1MEN1TSHRKMT2AHCRTR1 | |
| SCHEMBL4511386 | 0.77 | ALDH1A1 (0.36) | ALDH1A1MEN1TSHRKMT2AHCRTR1 | |
| SCHEMBL12096386 | 0.77 | ALDH1A1 (0.36) | ALDH1A1MEN1TSHRKMT2AHCRTR1 | |
| SCHEMBL4498947 | 0.77 | ALDH1A1 (0.36) | ALDH1A1MEN1TSHRKMT2AHCRTR1 | |
| SCHEMBL4521223 | 0.77 | ALDH1A1 (0.38) | ALDH1A1MEN1TSHRKMT2AHCRTR1 | |
| SCHEMBL5130772 | 0.77 | ALDH1A1 (0.38) | ALDH1A1MEN1TSHRKMT2AHCRTR1 | |
| SCHEMBL4521220 | 0.77 | ALDH1A1 (0.38) | ALDH1A1MEN1TSHRKMT2AHCRTR1 | |
| SCHEMBL4511392 | 0.71 | TSHR (0.48) | ALDH1A1MEN1TSHRKMT2AHCRTR1 | |
| SCHEMBL4511395 | 0.71 | TSHR (0.48) | ALDH1A1MEN1TSHRKMT2AHCRTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1953158-B1 | BICYCLIC CINNAMIDE COMPOUND | EISAI R&D MAN CO LTD (JP) | 2012-09-12 | — | — | EP | disclosed |
| US-20090181945-A1 | TWO CYCLIC CINNAMIDE COMPOUND | KIMURA TEIJI | 2009-07-16 | — | — | US | disclosed |
| EP-1953158-A1 | BICYCLIC CINNAMIDE COMPOUND | Eisai R&D Management Co., Ltd. (JP) | 2008-08-06 | — | — | EP | disclosed |
| US-20070117839-A1 | Two cyclic cinnamide compound | EISAI R&D MANAGEMENT CO., LTD. | 2007-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090181945-A1 | TWO CYCLIC CINNAMIDE COMPOUND | APP, BACE1, PSEN1 | ALDH1A1 869/4885MEN1 184/4885TSHR 4749/4885 |
| US-20070117839-A1 | Two cyclic cinnamide compound | APP, BACE1, PSEN1 | ALDH1A1 869/4885MEN1 184/4885TSHR 4749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.